Andrew Davis
Former Senior Vice President, Chief Business OfficeratIronwood Pharmaceuticals· In proxies 2021–2024
Pay in FY2024+8% from the year before · Ironwood Pharmaceuticals stock -61.3% the same year
Andrew Davis was paid $2.9M in FY2024 (Dec), up 8%. Ironwood Pharmaceuticals stock fell 61.3% that year.
Pay$100 in the stock at the end of FY20 → $39
Experience
- Ironwood PharmaceuticalsPublic company · 5 yr
- Former Senior Vice President, Chief Business Officer2021 – Present · 5 yrStock in role -69%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?